Miyaji Chikako, Miyakawa Ryoko, Watanabe Hisami, Kawamura Hiroki, Abo Toru
Department of Immunology, Niigata University School of Medicine, Japan.
Int Immunopharmacol. 2002 Jul;2(8):1079-86. doi: 10.1016/s1567-5769(02)00033-4.
Stronger neo-minophagen C (SNMC), a glycyrrhizin (GL) preparation, has been used for the treatment of chronic viral hepatitis. It has been reported that a single administration of SNMC induced the activation of hepatic lymphocytes in number and function in animal studies. However, it is still unknown how SNMC augments the cytotoxic function and why such augmentation of cytotoxicity occurs in the liver and other organs. In this study, SNMC was daily injected into mice (2 mg GL/day/mouse) for 2 weeks. A significant augmentation of cytotoxicity mediated by NK cells, NKT cells and TNFalpha was demonstrated mainly in the liver. The presence of TNFalpha-mediated cytotoxicity in the liver was demonstrated for the first time. In contrast to CD8+ cytotoxic T cells (CD8+ CTL), all these cytotoxicities were preexistent in lymphocytes without the immunization of a specific antigen or alloantigens. NK cytotoxicity was mediated by a perforin system, while NKT cytotoxicity was mediated by a Fas ligand system. The present results suggest that the entire cytotoxic function mediated by hepatic lymphocytes was simultaneously augmented by SNMC.
强力新甘草甜素(SNMC)是一种甘草甜素(GL)制剂,已用于治疗慢性病毒性肝炎。据报道,在动物研究中,单次给药SNMC可诱导肝淋巴细胞数量和功能的激活。然而,SNMC如何增强细胞毒性功能以及为何在肝脏和其他器官中会出现这种细胞毒性增强仍不清楚。在本研究中,每天给小鼠注射SNMC(2mg GL/天/只),持续2周。主要在肝脏中证实了由自然杀伤细胞(NK细胞)、自然杀伤T细胞(NKT细胞)和肿瘤坏死因子α(TNFα)介导的细胞毒性显著增强。首次在肝脏中证实了TNFα介导的细胞毒性的存在。与CD8 + 细胞毒性T细胞(CD8 + CTL)不同,所有这些细胞毒性在淋巴细胞中预先存在,无需特定抗原或同种异体抗原的免疫。NK细胞毒性由穿孔素系统介导,而NKT细胞毒性由Fas配体系统介导。目前的结果表明,SNMC可同时增强肝淋巴细胞介导的整体细胞毒性功能。